Maine Approves Inmar Intelligence as a Stewardship Organization for its Drug Take-Back Program
Retrieved on:
Wednesday, January 25, 2023
Water pollution, ScienceDirect, Medical statistics, Hospital, Water, National Center for Health Statistics, Law enforcement, Intelligence, Plasma protein binding, Drinking water, Garbage, Great State of Maine Air Show, Collection, Health care, Drug overdose, Prescription, Pharmacy, Medicine, Growth, United States drug overdose death rates and totals over time, OXO-biodegradation, Pharmaceutical industry
As a response to public health concerns, Maine and states across the U.S. have begun passing legislation mandating pharmaceutical manufacturer-funded drug stewardship programs.
Key Points:
- As a response to public health concerns, Maine and states across the U.S. have begun passing legislation mandating pharmaceutical manufacturer-funded drug stewardship programs.
- Inmar Intelligence is working with Maine and many of these other states to expand and enhance consumer drug take-back with a compliant, cost effective and cost-consistent solution.
- Maine residents had early access to the benefits of Inmar’s consumer drug take-back initiative based on existing operations in that state that started in 2022.
- Its drug stewardship program currently provides nearly 5,000 drug take-back receptacles across the country, with nearly 250 already operating in Maine, and continues to expand as states approve more mandated programs.